Kyungjoo Cho

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS).

Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS).

Journal: Cancers
Published: April 12, 2022

Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping.

Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping.

Journal: Nature communications
Published: March 01, 2022

A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor-β signaling.

A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor-β signaling.

Journal: American journal of cancer research
Published: November 23, 2021

Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma.

Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma.

Journal: International journal of molecular sciences
Published: November 02, 2021

YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation.

YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation.

Journal: Hepatology (Baltimore, Md.)
Published: September 05, 2020

Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with chronic liver disease.

Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with chronic liver disease.

Journal: Gut
Published: June 10, 2020

Genetically Engineered Mouse Models for Liver Cancer.

Genetically Engineered Mouse Models for Liver Cancer.

Journal: Cancers
Published: November 05, 2019

Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.

Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 19, 2017

Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgery.

Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgery.

Journal: The journal of obstetrics and gynaecology research
Published: May 25, 2016
Showing 1-9 of 9

Last Updated: 09/26/2026